Latest Fentanyl Stories
CUPERTINO, Calif., July 30, 2014 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) second quarter 2014 financial results press release, you are invited to listen to the
MELBOURNE, Australia, July 29, 2014 /PRNewswire/ -- -- Next phase of the TPM®/Oxymorphone clinical development program has commenced -- TPM®/Oxycodone Phase 2a trial to
NEWARK, Calif., July 25, 2014 /PRNewswire/ -- Depomed, Inc.
WASHINGTON, July 23, 2014 /PRNewswire-USNewswire/ -- For critically ill patients arriving at the emergency department, the drug ketamine can safely provide analgesia, sedation and amnesia for
Opinion Expected "In Short Order" NEWARK, Calif., July 17, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced that on July 17, 2014, Judge Joel A.
NEWARK, Calif., July 16, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced the appointment of Srinivas G. Rao, MD, PhD, as Chief Medical Officer and Senior Vice President.
- MAA submission triggers $5 million milestone payment to AcelRx REDWOOD CITY, Calif. and AACHEN, Germany, July 7, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
Las Vegas Rapid Detox Medical Clinic is pleased to announce that they reached the milestone of performing 500 successful rapid opiate detox procedures without any complications. Las
NEWARK, Calif., June 18, 2014 /PRNewswire/ -- Depomed, Inc.
NEWARK, Calif., June 10, 2014 /PRNewswire/ -- Depomed, Inc.
- A volcanic mudflow.